$3.07
0.010.33%
Últ. Act.: Nov 11, 9:58 AM
The average analyst price target for Anixa Biosciences is $9, 193.2% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $6 to $10. The latest change came on Sep 22, 2026, when HC Wainwright & Co. lowered its price target on Anixa Biosciences from $7 to $6 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months